Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Severe Congenital Ptosis Repair: A Report by the American Academy of Ophthalmology.

Ophthalmology·2026
Same author

The Role of Corticosteroids in the Management of Orbital Cellulitis: A Report by the American Academy of Ophthalmology.

Ophthalmology·2026
Same author

Health-Related Quality-of-Life Outcomes for Upper Blepharoplasty and Blepharoptosis Surgery: A Report by the American Academy of Ophthalmology.

Ophthalmology·2025
Same author

Orbital Patient-Specific (Customized) Implants: A Report by the American Academy of Ophthalmology.

Ophthalmology·2025
Same author

Pharmacologic Agents Used in the Assessment or Correction of Blepharoptosis: A Report by the American Academy of Ophthalmology.

Ophthalmology·2025
Same author

Vision-Threatening Complications of Soft Tissue Fillers: A Report by the American Academy of Ophthalmology.

Ophthalmology·2025

Related Experiment Video

Updated: Jun 21, 2026

Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo
08:17

Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo

Published on: September 22, 2017

Wegener granulomatosis causing compressive optic neuropathy in a child.

Vinay K Aakalu1, Amjad Z Ahmad

  • 1Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago,IL 60612, USA. vaakalu@uic.edu

Ophthalmic Plastic and Reconstructive Surgery
|July 21, 2009
PubMed
Summary

Wegener granulomatosis rarely causes compressive optic neuropathy in children. This case highlights successful treatment of unilateral vision loss and proptosis in a teen with this rare complication.

More Related Videos

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
08:55

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Published on: April 24, 2020

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Related Experiment Videos

Last Updated: Jun 21, 2026

Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo
08:17

Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo

Published on: September 22, 2017

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
08:55

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Published on: April 24, 2020

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Area of Science:

  • Ophthalmology
  • Rheumatology
  • Pediatrics

Background:

  • Wegener granulomatosis (WG), now known as granulomatosis with polyangiitis (GPA), is a rare autoimmune vasculitis.
  • Ophthalmic complications are common in WG/GPA, but compressive optic neuropathy is an infrequent manifestation, especially in pediatric patients.

Observation:

  • A 17-year-old male with a history of WG/GPA presented with acute unilateral vision loss, ocular pain, and proptosis in the left eye.
  • Ophthalmological examination revealed decreased visual acuity, pain on eye movement, and exophthalmos.
  • Computed tomography (CT) imaging demonstrated bilateral lacrimal gland enlargement causing compression of the left optic nerve.

Findings:

  • The patient received high-dose intravenous corticosteroids and daily oral cyclophosphamide.
  • Treatment led to a dramatic improvement in vision, resolution of ocular pain, and reduction of proptosis.
  • The patient was subsequently transitioned to maintenance therapy with mycophenolate mofetil and prednisone.

Implications:

  • This case underscores the importance of considering WG/GPA as a potential cause of compressive optic neuropathy in children and adolescents presenting with relevant ophthalmic symptoms.
  • Prompt diagnosis and aggressive immunosuppressive therapy are crucial for preserving vision and managing ocular complications in pediatric WG/GPA.
  • Ophthalmologists and rheumatologists should maintain a high index of suspicion for this rare but sight-threatening complication in affected children.